Miracor Revenue and Competitors

Miracor Medical is a European medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners. Miracor develops and studies the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. Recent Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients. The company is conducting further clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting). Miracor has won several innovation awards and completed financing rounds raising venture capital and public funding.